Recombinant Tissue Plasminogen Activator (Rtpa) and Stroke Unit for Acute Ischaemic Stroke in Developing Countries, Are They Cost-Effective?-Reference-Cited by-同舟云学术

Recombinant Tissue Plasminogen Activator (Rtpa) and Stroke Unit for Acute Ischaemic Stroke in Developing Countries, Are They Cost-Effective?

Author:

Shahtaheri Rahil Alsadat¹,Haghighi Afshin Borhani²³,Safari Anahid⁴,Cruz-Flores Salvador⁵

Affiliation:

1. Department of Health Economics, School of Health care Management, Shiraz University of Medical Sciences, Shiraz, Iran

2. Research Center for Transgenic Technology and Stem cell, Shiraz University of Medical Sciences, Shiraz, Iran

3. Departments of Neurology, Shiraz University of Medical Sciences, Shiraz, Iran

4. Research Center for Traditional Medicine and History of Medicine, Shiraz University of Medical Sciences, Shiraz, Iran

5. Department of Neurology, Saint Louis University, Saint Louis, MO, USA

Publisher

SAGE Publications

Subject

Neurology

Link

Reference4 articles.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献